NDIS Independent Pricing Review Update

Published 26 April 2018

Allied Health Professions Australia is pleased to announce that the National Disability Insurance Agency (NDIA) has provided formal notification that the planned implementation of therapy price limits (tiered therapy pricing) will not go ahead on July 1st, 2018. Instead the Agency has acknowledged that further work and consultation is required to ensure that any changes are safe and effective.

The Agency has provided a range of updates about the implementation of the various recommendations of the Independent Pricing Review undertaken by McKinsey & Company. The following recommendations are expected to be implemented on July 1st, 2018:

  • 4 – Regional Travel
  • 10 – Short Term Accommodation
  • 14 – Temporary Support for Overheads
  • 15 – Cancellation policy for core supports
  • 16 – Group supports
  • 18 – Therapy assistants (phase one)
  • 19 – Therapy travel
  • 20 – Cancellation policy for therapy
  • 21 – Reports requested by NDIA

AHPA is broadly supportive of these recommendations though we are seeking clarification on some aspects of the travel and report writing policies. In conjunction with our members, we have provided input to McKinsey and the NDIA to help support appropriate implementation of these recommendations.

The following recommendations will not go ahead on July 1st, 2018 and instead will be subject to additional work and consultation:

  • 6 – Defining complexity
  • 7 – Price tier that accounts for complexity of supports
  • 9 – High intensity loading for centre based activities
  • 17 – Therapy price limits
  • 18 – Therapy assistants (phase two)

AHPA continues to have significant concerns about these recommendations and the analysis that underpins these. We will continue our efforts to work closely with the Agency and McKinsey to ensure that they do not impact negatively on participants and providers.

To find out more about the changes to the Agency’s implementation timeline, please visit the NDIS website by clicking here. That link also provides access to information about the Independent Pricing Review.